Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Leboyer

Showing results (401-410 of 549) with videos related to

Pageof 55
Sort By:
Brain, Behavior, and Immunity|September 9, 2021
Low peripheral mitochondrial DNA copy number during manic episodes of bipolar disorders is associated with disease severity and inflammationLoïc Angrand, Wahid Boukouaci, Mohamed Lajnef, et al.
Brain, Behavior, & Immunity - Health|July 18, 2024
Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorderKatlyn Nemani, Livia De Picker, Faith Dickerson, et al.
Psychological Medicine|January 28, 2020
Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter studyFranz Hozer, Samuel Sarrazin, Charles Laidi, et al.
BMC Medical Genetics|January 22, 2011
Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disabilityCecile Pagan, Hany Goubran Botros, Karine Poirier, et al.
The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.
Biological Psychiatry|March 13, 2009
Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disordersChristel Depienne, Daniel Moreno-De-Luca, Delphine Heron, et al.
Plos One|July 27, 2010
Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general populationPauline Chaste, Nathalie Clement, Oriane Mercati, et al.
Journal of Affective Disorders|March 13, 2025
Clinical features and comorbidities associated with migraine in bipolar disorder: Results from the FACE-BD cohortLudovic Samalin, Ophelia Godin, Xavier Moisset, et al.
Biological Psychiatry|September 22, 2022
Cerebellar Atypicalities in Autism?Charles Laidi, Dorothea L Floris, Julian Tillmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 19, 2022
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trialWolfgang Strube, Aslihan Aksar, Ingrid Bauer, et al.
Pageof 55

Showing results (401-410 of 549) with videos related to

Sort By:
Pageof 55
Brain, Behavior, and Immunity|September 9, 2021
Low peripheral mitochondrial DNA copy number during manic episodes of bipolar disorders is associated with disease severity and inflammationLoïc Angrand, Wahid Boukouaci, Mohamed Lajnef, et al.
Brain, Behavior, & Immunity - Health|July 18, 2024
Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorderKatlyn Nemani, Livia De Picker, Faith Dickerson, et al.
Psychological Medicine|January 28, 2020
Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter studyFranz Hozer, Samuel Sarrazin, Charles Laidi, et al.
BMC Medical Genetics|January 22, 2011
Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disabilityCecile Pagan, Hany Goubran Botros, Karine Poirier, et al.
The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.
Biological Psychiatry|March 13, 2009
Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disordersChristel Depienne, Daniel Moreno-De-Luca, Delphine Heron, et al.
Plos One|July 27, 2010
Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general populationPauline Chaste, Nathalie Clement, Oriane Mercati, et al.
Journal of Affective Disorders|March 13, 2025
Clinical features and comorbidities associated with migraine in bipolar disorder: Results from the FACE-BD cohortLudovic Samalin, Ophelia Godin, Xavier Moisset, et al.
Biological Psychiatry|September 22, 2022
Cerebellar Atypicalities in Autism?Charles Laidi, Dorothea L Floris, Julian Tillmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 19, 2022
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trialWolfgang Strube, Aslihan Aksar, Ingrid Bauer, et al.
Pageof 55